Form 8-K - Current report:
SEC Accession No. 0001615774-17-004304
Filing Date
2017-08-14
Accepted
2017-08-14 07:02:48
Documents
3
Period of Report
2017-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s107157_8k.htm 8-K 14691
2 EXHIBIT 99.1 s107157_ex99-01.htm EX-99.01 41240
3 GRAPHIC logo_ex99-01.jpg GRAPHIC 11521
  Complete submission text file 0001615774-17-004304.txt   73164
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 171026832
SIC: 2834 Pharmaceutical Preparations